<SEC-DOCUMENT>0000899243-21-019978.txt : 20210519
<SEC-HEADER>0000899243-21-019978.hdr.sgml : 20210519
<ACCEPTANCE-DATETIME>20210519181956
ACCESSION NUMBER:		0000899243-21-019978
CONFORMED SUBMISSION TYPE:	3/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20201118
FILED AS OF DATE:		20210519
DATE AS OF CHANGE:		20210519

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Consonance Life Sciences
		CENTRAL INDEX KEY:			0001824774
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39635
		FILM NUMBER:		21941663

	BUSINESS ADDRESS:	
		STREET 1:		11 WESTCOTT ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		650-477-8183

	MAIL ADDRESS:	
		STREET 1:		11 WESTCOTT ROAD
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Consonance-HFW Acquisition Corp.
		CENTRAL INDEX KEY:			0001824893
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				981556622
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1 PALMER SQUARE
		STREET 2:		SUITE 305
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		(609) 921-2333

	MAIL ADDRESS:	
		STREET 1:		1 PALMER SQUARE
		STREET 2:		SUITE 305
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
</SEC-HEADER>
<DOCUMENT>
<TYPE>3/A
<SEQUENCE>1
<FILENAME>doc3a.xml
<DESCRIPTION>FORM 3/A SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3/A</documentType>

    <periodOfReport>2020-11-18</periodOfReport>

    <dateOfOriginalSubmission>2020-11-18</dateOfOriginalSubmission>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001824893</issuerCik>
        <issuerName>Consonance-HFW Acquisition Corp.</issuerName>
        <issuerTradingSymbol>CHFW</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001824774</rptOwnerCik>
            <rptOwnerName>Consonance Life Sciences</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O CONSONANCE-HFW ACQUISITION CORP.</rptOwnerStreet1>
            <rptOwnerStreet2>1 PALMER SQUARE, SUITE 305</rptOwnerStreet2>
            <rptOwnerCity>PRINCETON</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>08540</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Class B Ordinary Shares</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>2210000</value>
                    <footnoteId id="F1"/>
                    <footnoteId id="F2"/>
                    <footnoteId id="F4"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F3"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination.</footnote>
        <footnote id="F2">This number includes up to 300,000 shares that are subject to forfeiture in the event the underwriters of the initial public offering of the Issuer's securities do not exercise in full their over-allotment as described in the Issuer's registration statement.</footnote>
        <footnote id="F3">These shares are directly held by Consonance Life Sciences, LLC (&quot;Consonance Life Sciences&quot;).  This entity is governed by a board of managers consisting of Mitchell J. Blutt, Benny Soffer and Kevin Livingston.  As such, Mitchell J. Blutt, Benny Soffer and Kevin Livingston may be deemed to have voting and investment discretion with respect to these shares and may be deemed to have shared beneficial ownership of these shares.  Each of Mitchell J. Blutt, Benny Soffer and Kevin Livingston disclaims beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.</footnote>
        <footnote id="F4">This Form 3 amendment is being filed to correct the original Form 3 filed on November 18, 2020. The original Form 3 incorrectly listed the amount of the securities as 2,300,000 Class B Ordinary Shares held by Consonance Life Sciences and incorrectly reported such shares in Table II.</footnote>
    </footnotes>

    <remarks>Consonance Life Sciences, LLC (&quot;Consonance Life Sciences&quot;) is governed by a board of managers consisting of Mitchell Blutt, Benny Soffer and Kevin Livingston. Dr. Blutt is the Chairman of the Board of Directors (the &quot;Board&quot;) of Consonance-HFW Acquisition Corp. (the &quot;Issuer&quot;). By virtue of its representation on the Issuer's Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, Consonance Life Sciences is deemed a director by deputization of the Issuer.</remarks>

    <ownerSignature>
        <signatureName>/s/ Kevin Livingston, Manager of Consonance Life Sciences, LLC</signatureName>
        <signatureDate>2021-05-19</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
